Clal Biotechnology (Israel) Today
| CBI Stock | 51.00 0.80 1.59% |
Performance19 of 100
| Odds Of DistressLess than 20
|
Clal Biotechnology is trading at 51.00 as of the 7th of May 2024, a 1.59 percent up since the beginning of the trading day. The stock's open price was 50.2. Clal Biotechnology has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Equity ratings for Clal Biotechnology Industries are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of April 2024 and ending today, the 7th of May 2024. Click here to learn more.
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. The company has 156.85 M outstanding shares. More on Clal Biotechnology Industries
Moving together with Clal Stock
| 0.64 | HRON | Hiron Trade Investments | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Clal Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Clal Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Clal Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Ideas | (View all Themes) |
| Business Concentration | IT, Computers, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors) |
Clal Biotechnology Industries (CBI) is traded on Tel Aviv Stock Exchange in Israel and employs 21 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 122.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clal Biotechnology's market, we take the total number of its shares issued and multiply it by Clal Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Clal Biotechnology operates under Biotechnology sector and is part of Health Care industry. The entity has 156.85 M outstanding shares.
Clal Biotechnology Industries has accumulated about 94.71 M in cash with (41.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59.
Check Clal Biotechnology Probability Of Bankruptcy
Ownership AllocationClal Biotechnology holds a total of 156.85 Million outstanding shares. Clal Biotechnology Industries shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.58 percent of Clal Biotechnology outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Clal Ownership Details
Clal Stock Price Odds Analysis
What are Clal Biotechnology's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Clal Biotechnology jumping above the current price in 90 days from now is near 1%. The Clal Biotechnology Industries probability density function shows the probability of Clal Biotechnology stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Clal Biotechnology has a beta of 0.1483 suggesting as returns on the market go up, Clal Biotechnology average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Clal Biotechnology Industries will be expected to be much smaller as well. Additionally, clal Biotechnology Industries has an alpha of 0.3081, implying that it can generate a 0.31 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Clal Biotechnology to move above the current price in 90 days from now is near 1 (This Clal Biotechnology Industries probability density function shows the probability of Clal Stock to fall within a particular range of prices over 90 days) .
Clal Biotechnology Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Clal Biotechnology market risk premium is the additional return an investor will receive from holding Clal Biotechnology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Clal Biotechnology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Clal Biotechnology's alpha and beta are two of the key measurements used to evaluate Clal Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.08 | |||
| Semi Deviation | 2.52 | |||
| Standard Deviation | 2.73 | |||
| Variance | 7.47 |
Clal Stock Against Markets
Picking the right benchmark for Clal Biotechnology stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Clal Biotechnology stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Clal Biotechnology is critical whether you are bullish or bearish towards Clal Biotechnology Industries at a given time. Please also check how Clal Biotechnology's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clal Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Clal Biotechnology Corporate Management
Elected by the shareholders, the Clal Biotechnology's board of directors comprises two types of representatives: Clal Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clal. The board's role is to monitor Clal Biotechnology's management team and ensure that shareholders' interests are well served. Clal Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clal Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Assaf Segal | Acting Officer | Profile | |
| Iris Sadeh | Accountant | Profile | |
| Liat Nissan | Controller | Profile | |
| Shiran Manor | Co Sec | Profile | |
| Etty Kliger | VP MediWound | Profile | |
| Arnon MD | Medical Director | Profile | |
| Pr MD | VP MediWound | Profile |
How to buy Clal Stock?
Before investing in Clal Biotechnology, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Clal Biotechnology. To buy Clal Biotechnology stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Clal Biotechnology. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Clal Biotechnology stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Clal Biotechnology Industries stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Clal Biotechnology Industries stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Clal Biotechnology Industries, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Clal Biotechnology Industries?
The danger of trading Clal Biotechnology Industries is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Clal Biotechnology is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Clal Biotechnology. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Clal Biotechnology is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clal Biotechnology Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Clal Stock analysis
When running Clal Biotechnology's price analysis, check to measure Clal Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clal Biotechnology is operating at the current time. Most of Clal Biotechnology's value examination focuses on studying past and present price action to predict the probability of Clal Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clal Biotechnology's price. Additionally, you may evaluate how the addition of Clal Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |